Diagnostic Endoscopic Retrograde Cholangiopancreatography

Although diagnostic endoscopic retrograde cholangiopancreatography (ERCP) has been replaced in many fields by magnetic resonance cholangiopancreatography (MRCP), considerable amounts of research are still ongoing. Major fields of interest include ways of reducing the incidence of post-ERCP pancreatitis, new ways of improving the yield of tissue sampling, and the diagnosis of sphincter of Oddi dysfunction. In addition, there are new data comparing the diagnostic accuracy of ERCP with that of MRCP and endoscopic ultrasonography.

References

• 1 Ciocirlan M, Ponchon T. Diagnostic endoscopic cholangiopancreatography.  Endoscopy. 2004;  36 136-146
• 2 Rodríguez-González F JR, Naránjo-Rodríguez A, Mata-Tapia I. et al . ERCP in patients 90 years of age and older.  Gastrointest Endosc. 2003;  58 220-225
• 3 Johnston S D, McKenna A, Tham T CK. Silent myocardial ischaemia during endoscopic retrograde cholangiopancreatography.  Endoscopy. 2003;  35 1039-1042
• 4 Masci E, Mariani A, Curioni S. et al . Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis.  Endoscopy. 2003;  35 830-834
• 5 Hackert T, Werner J, Gebhard M M. et al . Effects of heparin in experimental models of acute pancreatitis and post-ERCP pancreatitis.  Surgery. 2004;  135 131-138
• 6 Rabenstein T, Fischer B, Wiessner V. et al . Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis.  Gastrointest Endosc. 2004;  59 606-613
• 7 Poon R TP, Yeung C, Liu C L. et al . Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial.  Gut. 2003;  52 1768-1773
• 8 Arvanitidis D, Anagnostopoulos G K, Giannopoulos D. et al . Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial.  J Gastroenterol Hepatol. 2004;  19 278-282
• 9 Cavallini G, Tittobello A, Frulloni L. et al . Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in Digestive Endoscopy - Italian Group.  N Engl J Med. 1996;  335 919-923
• 10 Masci E, Cavallini G, Mariani A. et al . Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis.  Am J Gastroenterol. 2003;  98 2182-2186
• 11 Perney P, Berthier E, Pageaux G P. et al . Are drugs a risk factor of post-ERCP pancreatitis?.  Gastrointest Endosc. 2003;  58 696-700
• 12 Lella F, Bagnolo F, Colombo E. et al . A simple way of avoiding post-ERCP pancreatitis.  Gastrointest Endosc. 2004;  59 830-834
• 13 Fazel A, Quadri A, Catalano M. et al . Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study.  Gastrointest Endosc. 2003;  57 291-294
• 14 Laasch H U, Tringali A, Wilbraham L. et al . Comparison of standard and steerable catheters for bile duct cannulation in ERCP.  Endoscopy. 2003;  35 669-674
• 15 Sweeney J T, Shah R J, Martin S P. et al . The impact of post-procedure interpretation of ERCP X-ray films by radiologists on patient care: should it be routine or selective?.  Gastrointest Endosc. 2003;  58 549-553
• 16 Kowalski T, Kanchana T, Pungpapong S. Perceptions of gastroenterology fellows regarding ERCP competency and training.  Gastrointest Endosc. 2003;  58 345-349
• 17 Griffin N, Wastle M L, Dunn W K. et al . Magnetic resonance cholangiopancreatography versus endoscopic retrograde cholangiopancreatography in the diagnosis of choledocholithiasis.  Eur J Gastroenterol Hepatol. 2003;  15 809-813
• 18 Talwalkar J A, Angulo P, Johnson C D. et al . Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis.  Hepatology. 2004;  40 39-45
• 19 Hünerbein M, Stroszczynski C, Ulmer C. et al . Prospective comparison of transcutaneous 3-dimensional US cholangiography, magnetic resonance cholangiography, and direct cholangiography in the evaluation of malignant biliary obstruction.  Gastrointest Endosc. 2003;  58 853-858
• 20 Seifert H, Wehrmann T, Hilgers R. et al . Catheter probe extraductal EUS reliably detects distal common bile duct abnormalities.  Gastrointest Endosc. 2004;  60 61-67
• 21 Meenan J, Tibble J, Prasad P. et al . The substitution of endoscopic ultrasound for endoscopic retrograde cholangiopancreatography: implications for service development and training.  Eur J Gastroenterol Hepatol. 2004;  16 299-303
• 22 Wilcox C M, Linder J. Prospective evaluation of droperidol on sphincter of Oddi motility.  Gastrointest Endosc. 2003;  58 483-487
• 23 Fogel E L, Sherman S, Bucksot L. et al . Effects of droperidol on the pancreatic and biliary sphincters.  Gastrointest Endosc. 2003;  58 488-492
• 24 Singh P, Gurudu S R, Davidoff S. et al . Sphincter of Oddi manometry does not predispose to post-ERCP acute pancreatitis.  Gastrointest Endosc. 2004;  59 499-505
• 25 Mariani A, Curioni S, Zanello A. et al . Secretin MRCP and endoscopic pancreatic manometry in the evaluation of sphincter of Oddi function: a comparative pilot study in patients with idiopathic recurrent pancreatitis.  Gastrointest Endosc. 2003;  58 847-852
• 26 Varadarajulu S, Hawes R H, Cotton P B. Determination of sphincter of Oddi dysfunction in patients with prior normal manometry.  Gastrointest Endosc. 2003;  58 341-344
• 27 Rashdan A, Fogel E, McHenry L. et al . Frequency of biliary crystals in patients with suspected sphincter of Oddi dysfunction.  Gastrointest Endosc. 2003;  58 875-878
• 28 Lin L F, Slauw C P, Ho K S. et al . Guidewire technique for endoscopic transpapillary procurement of bile duct biopsy specimens without endoscopic sphincterotomy.  Gastrointest Endosc. 2003;  58 272-274
• 29 Siddiqui M T, Gokasian S T, Saboorian M H. et al . Comparison of ThinPrep and conventional smears in detecting carcinoma in bile duct brushings.  Cancer. 2003;  99 205-210
• 30 Duggan M A, Brasher P, Medlicott S A. ERCP-directed brush cytology prepared by the ThinPrep method: test performance and morphology of 149 cases.  Cytopathology. 2004;  15 80-86
• 31 De Bellis M, Fogel E L, Sherman S. et al . Influence of stricture dilation and repeat brushing on the cancer detection rate of brush cytology in the evaluation of malignant biliary obstruction.  Gastrointest Endosc. 2003;  58 176-182
• 32 Rösch T, Hofrichter K, Frimberger E. et al . ERCP or EUS for tissue diagnosis of biliary strictures? A prospective comparative study.  Gastrointest Endosc. 2004;  60 390-396
• 33 Zhou G X, Huang J F, Li Z S. et al . Detection of K-ras point mutation and telomerase activity during endoscopic retrograde cholangiopancreatography in diagnosis of pancreatic cancer.  World J Gastroenterol. 2004;  10 1337-1340
• 34 Arvanitakis M, van Laethem J L, Parma J. et al . Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation.  Endoscopy. 2004;  36 535-542
• 35 Inoue K, Ohuchida J, Ohtsuka T. et al . Severe localized stenosis and marked dilatation of the main pancreatic duct are indicators of pancreatic cancer instead of chronic pancreatitis on endoscopic retrograde balloon pancreatography.  Gastrointest Endosc. 2003;  58 510-515